Enantiomeric entactogen compositions and their use Grant US-11939312-B2 United States of America 26 Mar 2024
USE OF MDMA FOR TREATMENT OF STRESS-RELATED DISORDERS Application WO-2024052880-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
Nitric oxide releasing prodrugs of MDA and MDMA Grant US-11912680-B2 United States of America 27 Feb 2024
Prodrugs of MDMA, MDA, and derivatives thereof Grant US-11845736-B2 United States of America 19 Dec 2023
Advantageous benzofuran compositions for mental disorders or enhancement Grant US-11767305-B2 United States of America 26 Sep 2023
R-MDMA AND S-MDMA TO ASSIST PSYCHOTHERAPY Application WO-2023131841-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2023
COMPOSITIONS COMPRISING NON-RACEMIC MIXTURES OF (R)- AND (S)-3,4-METHYLENEDIOXYMETHAMPHETAM… Application WO-2023019369-A1 World Intellectual Property Organisation (WIPO) 23 Feb 2023
SAFER PSYCHOACTIVE COMPOSITIONS Application WO-2023283386-A3 World Intellectual Property Organisation (WIPO) 23 Feb 2023
MDMA ENANTIOMERS Application WO-2022235530-A1 World Intellectual Property Organisation (WIPO) 10 Nov 2022
MDMA IN THE TREATMENT OF ALCOHOL USE DISORDER Application WO-2022150525-A1 World Intellectual Property Organisation (WIPO) 14 Jul 2022